We report the clinical observation of an HIV-positive/AIDS patient with bilateral macular hemorrhage, which resulted in the identification of severe thrombocytopenia. Thrombocytopenia is a common hematologic anomaly during HIV infection. Its frequency increases with the decrease in CD4 T lymphocytes and the passage to the AIDS stage. Its pathophysiology in this context is complex and multifactorial. Hemorrhagic complications usually appear for platelets less than 50,000/mm 3 and this risk is greater at a rate of less than 20,000/mm 3 . Retinal hemorrhages may go unnoticed, only macular localization results in clinical expression. OCT is of paramount importance in accurate topographic diagnosis of macular hemorrhages by locating their seats which can be pre, intra or under retinal. Management requires the balance of infectious and hematologic factors. Ophthalmic surgical treatments should be considered in a second step.
Introduction
Macular hemorrhage can complicate several pathologies, such as proliferative diabetic retinopathy, retinal arterial and venous macro-aneurysms, Valsalva retinopathy; retinal venous branch occlusions, trauma and more rarely do hema-tologic disorders [1] .
Thrombocytopenia is a hematologic disorder which prevalence in adults infected by HIV/AIDS and those free of any antiretroviral therapy is variable according to many studies [2] [3] . The pathophysiological mechanism and etiopathogeny of this hematological disorder during this condition are currently established, with a dual peripheral and central component [4] [5] . These two components give different clinical presentations according to the predominant pathophysiological mechanism. The peripheral thrombocytopenia is precocious, often moderate with severe hemorrhages infrequent. The form of central origin is usually late, deep with a more frequent hemorrhagic syndrome and associated with other Cytopenias [5] . Thrombocytopenia can be discovered during the systematic realization of a CBC or in the presence of hemorrhagic skin and/or mucous signs. We report the clinical observation of an HIV-positive/AIDS patient with bilateral macular hemorrhage that revealed severe thrombocytopenia. HIV-related complications. At one month's follow-up, the patient died as a result of lightning herpetic encephalitis.
Observation

Discussion
Thrombocytopenia is a hematologic abnormality that occurs frequently during HIV infection [ [6] . The frequency also increases with the decrease of CD4 T cell count and progression to AIDS [7] [8]. Our patient had accumulated these two important risk factors of hemorrhagic complications. The circumstances in which thrombocytopenia can be detected can be achieved by the systematic completion of a blood count or the presence of hemorrhagic signs [6] . Serious visceral bleeding disorders, whether digestive, cerebro-meningeal or retinal, are exceptional [6] . Retinal hemorrhages may be undetected, only macular localization leads to clinical expression. Indeed, the bilateral macular hematoma responsible for sudden blindness was the mode of revelation of thrombocytopenia in our patient. This is an unusual mode of revelation of thrombocytopenia on a deeply immuno-compromised field. Optical coherence tomography has been of great help in this case, by localizing the exact seat of the hematological collection. Indeed, this examination is of paramount importance in the precise topographic diagnosis of macular hemorrhage by localizing their sites, which can be pre, intra or sub-retinal; it is also an important examination in the evolutionary follow-up [1] . The sub-retinal location of the hemorrhage is usually of bad prognostic no matter the etiologies [9] [10]. In spite of the simple ophthalmological follow up, we nevertheless observed an improvement in visual acuity in our patient, probably because of the management of the infectious and immunological mechanisms involved in thrombocytopenia. Indeed, it has been improved that the reintroduction of antiretrovirals has been shown to lead to a rapid improvement in platelet medullary production [5] [11] [12] . In opposite to other etiologies responsible for sub-retinal hemorrhages, short-term visual recovery was better in this case. However, in the medium term, follow up was not possible because of the patient's death following other complications related to HIV/AIDS. If total macular hemorrhage is not resorbed within 2-3 weeks, there is the possibility of irreversible damage due to the direct toxicity of the red blood cells over the retinal cells and the pigment epithelium [9] [10] [13] . This risk is most important as the hemorrhage is subretinal in relation to the pre-retinal localization [9] [10] [13] . This is a therapeutic emergency when the resorption at 2 weeks of progression of the hematoma is not complete [1] [9] . The management will then require surgery either by drainage of the hematoma with the addition of a tissue activator of the plasminogen (rPA) allowing the liquefaction of the clot, or by displacement of the hematoma to the retinal periphery after intraocular gas injection with or without rPA [1] - [10] . 
Conclusion
